title: [Tinea in glabrous skin: total quality management].
abstract: Today tinea of glabrous skin still is one of the central diagnostic and therapeutic problems in dermatology. The choice of the adequate treatment is always influenced by the type of microorganism, the site of manifestation, time course and severity of the infection as well as by the immune status of the patient. Tinea has to be differentiated from other skin diseases. Thus, general guide lines for diagnostic processing are needed. Adequate treatment with various types of antimycotics either is topical or--less frequently--systemic.
authors.affiliation: Dermatologische Klinik und Poliklinik der Ludwig-Maximilians-Universität München.
authors.forename: J
authors.initials: J
authors.lastname: Bastert
authors.forename: H C
authors.initials: HC
authors.lastname: Korting
mesh_terms: D000287:Administration, Topical; D000935:Antifungal Agents / Q000008:administration & dosage; D003937:Diagnosis, Differential; D006801:Humans; D011785:Quality Assurance, Health Care; D014005:Tinea / Q000175:diagnosis* / Q000188:drug therapy
chemical_list: D000935:Antifungal Agents
vernacular_title: Tinea der freien Haut: Gütegesichertes Management.